3/27
08:07 am
cprx
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $29.00 price target on the stock.
Low
Report
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $29.00 price target on the stock.
3/27
07:30 am
cprx
Rating for CPRX
Low
Report
Rating for CPRX
3/27
07:30 am
cprx
Rating for CPRX
Low
Report
Rating for CPRX
3/22
02:32 pm
cprx
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $34.00 price target on the stock.
Low
Report
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $34.00 price target on the stock.
3/22
01:59 pm
cprx
Rating for CPRX
Low
Report
Rating for CPRX
3/18
03:06 pm
cprx
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $34.00 price target on the stock.
Low
Report
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $34.00 price target on the stock.
3/14
10:18 am
cprx
Rating for CPRX
Low
Report
Rating for CPRX
3/14
08:08 am
cprx
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $27.00 price target on the stock.
Low
Report
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $27.00 price target on the stock.
3/14
08:01 am
cprx
Rating for CPRX
Medium
Report
Rating for CPRX
3/14
08:01 am
cprx
Rating for CPRX
Medium
Report
Rating for CPRX
3/13
06:22 pm
cprx
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating.
Low
Report
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating.
3/1
09:51 am
cprx
Rating for CPRX
Low
Report
Rating for CPRX
3/1
08:14 am
cprx
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Medium
Report
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.